Iridian Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,074
Closed -$1.1M 63
2021
Q4
$1.1M Hold
4,074
0.07% 60
2021
Q3
$985K Hold
4,074
0.03% 65
2021
Q2
$965K Hold
4,074
0.02% 77
2021
Q1
$893K Hold
4,074
0.02% 84
2020
Q4
$712K Buy
+4,074
New +$704K 0.01% 78

Other funds holding LH

Iridian Asset Management's LH Position: Q1 2026 in Review

Iridian Asset Management reduced its Labcorp (LH) stake by 22% in Q1 2026, selling an estimated $221K and leaving 2,827 shares worth $754K. The position accounts for 0.31% of the portfolio, ranked #36.

Iridian Asset Management first reported a position in LH in Q3 2016 and has held it in 39 quarters since. The position peaked at $316M in Q2 2018. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Iridian Asset Management held 2,827 shares of Labcorp worth $754K as of Q1 2026.
  • Iridian Asset Management sold 817 Labcorp shares in Q1 2026, an estimated $221K.
  • Labcorp made up 0.31% of Iridian Asset Management's portfolio in Q1 2026, its #36 holding.
  • Iridian Asset Management first reported a position in Labcorp in Q3 2016 and has held it in 39 quarters since.
  • Iridian Asset Management's Labcorp position peaked at $316M in Q2 2018.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Iridian Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.